1 month ago

Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects

Share this!

Read Entire Article
  1. Homepage
  2. Finance
  3. Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects

Related

Spire Analysts Boost Their Forecasts After Q4 Results

Spire Analysts Boost Their Forecasts After Q4 Results

4 minutes ago
MicroStrategy Surges 674% In 2024: 5 ETFs That Benefit From MSTR's Bitcoin-Driven Growth

MicroStrategy Surges 674% In 2024: 5 ETFs That Benefit From ...

4 minutes ago
These Analysts Boost Their Forecasts On Wix.com After Upbeat Earnings

These Analysts Boost Their Forecasts On Wix.com After Upbeat...

11 minutes ago

© NewsMage 2024. All rights are reserved

About Us · Contact Us · Follow Us ·